We are stewards of healthcare inventions, creating the optimal conditions to help them grow from idea to execution.

As an investment and incubator firm focused on accelerating the commercialization of medical technologies, Waterston Capital bridges the gap between promising startup innovations and large-scale commercialization in the healthcare sector.

By providing the necessary entrepreneurial expertise, capital, and strategic guidance, we foster groundbreaking inventions, connect research to revenue generators, and align financial success with positive societal impact.

Our Epiphany: 

The current direction of MedTech innovation is all wrong.

We shouldn't be focused on value extraction. We should be focused on value CREATION. And by combining the benefits of diversified portfolios with principled financial discipline, we are reinventing the wheel for a new era while outsmarting richer, more traditional VC firms. 

At Waterston Capital, we're breaking the model by nurturing the underestimated inventors and concepts other VCs might ignore—early-stage products and technology that have the potential to make medicine safer, more effective and more efficient for physicians and clinicians, while dramatically impacting patient care.  

We not only nurture products that have the potential to radically transform the industry, we also solve problems that others overlook by focusing on small improvements that drive steady, repeatable growth.

And we create value for our shareholders while building economies, supporting our inventors, and delivering consistent innovation to the highly impactful and competitive MedTech market. By actually building a team around the technology and its inventor, as opposed to just offering advice, we are able to move products more quickly and effectively to commercialization.

At the end of the day, we're not in this just to make money—although we do make money.

We're in this to create value for and share rewards with inventors, universities, institutions, investors, researchers, manufacturers and, most importantly, the people whose lives will be touched (and possibly saved) by the new technologies we help bring to market.

Humanity First

The inventions we champion are those designed with better patient outcomes in mind. We believe that, if we care about helping people first, the money will follow. By fostering long-term partnerships with inventors and generating substantial returns for investors, we develop life-altering technologies that might never have seen the light of day were it not for our intervention.

We believe our unique blend of compassion, optimism, and business acumen as well as our ability to foster long-term partnerships with inventors and generate substantial returns for investors will not only inspire hope for the future of healthcare, it will actually make it better.

Trust is Key

We bridge the gap between invention and application so it's crucial that our partners trust us to help nurture, grow, and properly exit the products entrusted to our care. Specifically:

  • Inventors trust us to be stewards of their invention

  • Universities and institutions trust us to bring technologies to life and deliver a high return

  • Manufacturers trust us to bring them valuable offerings

  • All groups trust us to connect them to one another 

We ensure communication flows both ways by bringing new, life-altering technologies to small- and mid-cap medical device manufacturers AND by helping manufacturers fill known gaps in the marketplace by sharing their needs with inventors. We've seen, time and again, what a huge difference a radical new technology or even a small improvement to an existing technology can make, and we love nothing more than hearing, "we've been waiting for that!"

Low risk.
High reward.

When we acquire a new technology, we greatly reduce the risk for inventors, universities and manufacturers. By taking on a rigorous 8-step due diligence process, validation testing, pre-clinical trials and R&D work, we are able to help inventors and early-stage MedTech companies overcome the challenges they would normally face in developing and commercializing their technologies. At the same time, we can ensure a strong return on investment for investors by identifying and developing healthcare technologies with high commercial potential while significantly reducing the cost for research and development.

Once we have completed our initial due diligence, we turn to a highly experienced, independent due diligence committee comprised of physicians from Harvard and The Cleveland Clinic; top executives from BSX, MDT, J&J, PE; and highly insightful investment bankers. Because this elite group of professionals knows exactly what to look for, they never just say "yes" or "no." If they're vetting a technology that shows great promise but needs to be tweaked to be commercially viable, they provide in-depth feedback to the inventor to help them make the changes that will lead to success.

We know that even the coolest new technology in the world isn't cool if it doesn't solve the problem. Inventors need to love the problem more than the solution so they're open to feedback when something needs to be changed. We give that feedback, and hope they listen.

Driving innovation.
Delivering results.
Deepening connection.

Our ultimate goal is to transform healthcare by making it more affordable, accessible, effective and safe for patients and clinicians while ensuring inventors rand universities receive the credit and remuneration they deserve. 

Our Waterston Accelerator Fund provides us with the capital needed to nurture the cutting-edge medical technology that leaves an indelible mark on humanity.  We truly believe that you can make money AND make positive change in the world; you simply need to care enough to do it thoughtfully, carefully, and one amazing invention at a time.